BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 30585368)

  • 1. Quantitative 3T multiparametric MRI of benign and malignant prostatic tissue in patients with and without local recurrent prostate cancer after external-beam radiation therapy.
    Dinis Fernandes C; van Houdt PJ; Heijmink SWTPJ; Walraven I; Keesman R; Smolic M; Ghobadi G; van der Poel HG; Schoots IG; Pos FJ; van der Heide UA
    J Magn Reson Imaging; 2019 Jul; 50(1):269-278. PubMed ID: 30585368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiparametric MRI Tumor Probability Model for the Detection of Locally Recurrent Prostate Cancer After Radiation Therapy: Pathologic Validation and Comparison With Manual Tumor Delineations.
    Dinis Fernandes C; Simões R; Ghobadi G; Heijmink SWTPJ; Schoots IG; de Jong J; Walraven I; van der Poel HG; van Houdt PJ; Smolic M; Pos FJ; van der Heide UA
    Int J Radiat Oncol Biol Phys; 2019 Sep; 105(1):140-148. PubMed ID: 31085288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative 3-T multi-parametric MRI and step-section pathology of recurrent prostate cancer patients after radiation therapy.
    Dinis Fernandes C; Ghobadi G; van der Poel HG; de Jong J; Heijmink SWTPJ; Schoots I; Walraven I; van Houdt PJ; Smolic M; Pos FJ; van der Heide UA
    Eur Radiol; 2019 Aug; 29(8):4160-4168. PubMed ID: 30421016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring radiotherapy induced tissue changes in localized prostate cancer by multi-parametric magnetic resonance imaging (MP-MRI).
    Wu X; Reinikainen P; Kapanen M; Vierikko T; Ryymin P; Kellokumpu-Lehtinen PL
    Diagn Interv Imaging; 2019 Nov; 100(11):699-708. PubMed ID: 31257114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probing structure of normal and malignant prostate tissue before and after radiation therapy with luminal water fraction and diffusion-weighted MRI.
    Carlin D; Orton MR; Collins D; deSouza NM
    J Magn Reson Imaging; 2019 Aug; 50(2):619-627. PubMed ID: 30589150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histopathological Features of MRI-Invisible Regions of Prostate Cancer Lesions.
    van Houdt PJ; Ghobadi G; Schoots IG; Heijmink SWTPJ; de Jong J; van der Poel HG; Pos FJ; Rylander S; Bentzen L; Haustermans K; van der Heide UA
    J Magn Reson Imaging; 2020 Apr; 51(4):1235-1246. PubMed ID: 31588646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection and staging of radio-recurrent prostate cancer using multiparametric MRI.
    Kowa JY; Soneji N; Sohaib SA; Mayer E; Hazell S; Butterfield N; Shur J; Ap Dafydd D
    Br J Radiol; 2021 Apr; 94(1120):20201423. PubMed ID: 33586998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of semi-quantitative and quantitative analysis of functional parameters in multiparametric MRI of the prostate.
    Hauth E; Halbritter D; Jaeger H; Hohmuth H; Beer M
    Br J Radiol; 2017 Oct; 90(1078):20170067. PubMed ID: 28749167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraductal carcinoma of the prostate (IDC-P) lowers apparent diffusion coefficient (ADC) values among intermediate risk prostate cancers.
    Currin S; Flood TA; Krishna S; Ansari A; McInnes MDF; Schieda N
    J Magn Reson Imaging; 2019 Jul; 50(1):279-287. PubMed ID: 30585372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative contrast-enhanced perfusion kinetics in multiparametric MRI in differentiating prostate cancer from chronic prostatitis: results from a pilot study.
    Sureka B; Elhence P; Khera PS; Choudhary GR; Pandey H; Garg PK; Yadav K; Goel A
    Br J Radiol; 2019 Aug; 92(1100):20190181. PubMed ID: 31184934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of bone metastases from prostate cancer and benign red marrow depositions of the pelvic bone with multiparametric MRI.
    Park S; Park JG; Jun S; Kim H; Kim TS; Kang H
    Magn Reson Imaging; 2020 Nov; 73():118-124. PubMed ID: 32860869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and Grading of Prostate Cancer by Relaxation Maps From Synthetic MRI.
    Cui Y; Han S; Liu M; Wu PY; Zhang W; Zhang J; Li C; Chen M
    J Magn Reson Imaging; 2020 Aug; 52(2):552-564. PubMed ID: 32027071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiparametric MRI for detection of radiorecurrent prostate cancer: added value of apparent diffusion coefficient maps and dynamic contrast-enhanced images.
    Abd-Alazeez M; Ramachandran N; Dikaios N; Ahmed HU; Emberton M; Kirkham A; Arya M; Taylor S; Halligan S; Punwani S
    Prostate Cancer Prostatic Dis; 2015 Jun; 18(2):128-36. PubMed ID: 25644248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can quantitative analysis of multi-parametric MRI independently predict failure of focal salvage HIFU therapy in men with radio-recurrent prostate cancer?
    Rakauskas A; Shah TT; Peters M; Randeva JS; Hosking-Jervis F; Schmainda MJ; Orczyck C; Emberton M; Arya M; Moore C; Ahmed HU
    Urol Oncol; 2021 Dec; 39(12):830.e1-830.e8. PubMed ID: 34049783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiparametric MRI in detection and staging of prostate cancer.
    Boesen L
    Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haralick textural features on T
    Gnep K; Fargeas A; Gutiérrez-Carvajal RE; Commandeur F; Mathieu R; Ospina JD; Rolland Y; Rohou T; Vincendeau S; Hatt M; Acosta O; de Crevoisier R
    J Magn Reson Imaging; 2017 Jan; 45(1):103-117. PubMed ID: 27345946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4D perfusion CT of prostate cancer for image-guided radiotherapy planning: A proof of concept study.
    Beer L; Polanec SH; Baltzer PAT; Schatzl G; Georg D; Schestak C; Dutschke A; Herrmann H; Mazal P; Brendel AK; Shariat SF; Ringl H; Helbich TH; Apfaltrer P
    PLoS One; 2019; 14(12):e0225673. PubMed ID: 31856177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative diffusion-weighted imaging and dynamic contrast-enhanced characterization of the index lesion with multiparametric MRI in prostate cancer patients.
    Yuan Q; Costa DN; Sénégas J; Xi Y; Wiethoff AJ; Rofsky NM; Roehrborn C; Lenkinski RE; Pedrosa I
    J Magn Reson Imaging; 2017 Mar; 45(3):908-916. PubMed ID: 27442039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DCE-MRI of the prostate using shutter-speed vs. Tofts model for tumor characterization and assessment of aggressiveness.
    Hectors SJ; Besa C; Wagner M; Jajamovich GH; Haines GK; Lewis S; Tewari A; Rastinehad A; Huang W; Taouli B
    J Magn Reson Imaging; 2017 Sep; 46(3):837-849. PubMed ID: 28092414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.